S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
Log in

OTCMKTS:CLIGF - Clinigen Group Stock Price, Forecast & News

$11.37
0.00 (0.00 %)
(As of 02/26/2020 04:00 PM ET)
Today's Range
$11.37
Now: $11.37
$11.37
50-Day Range
$11.37
MA: $12.13
$12.30
52-Week Range
$10.17
Now: $11.37
$12.30
Volume46 shs
Average Volume7 shs
Market Capitalization$1.39 billion
P/E Ratio16.48
Dividend YieldN/A
Beta-0.33

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CLIGF
Previous SymbolNASDAQ:CLIGF
CUSIPN/A
CIKN/A
Phone44-12-8349-5010

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$591.34 million
Cash Flow$1.19 per share
Book Value$4.68 per share

Profitability

Miscellaneous

Employees1,133
Market Cap$1.39 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive CLIGF News and Ratings via Email

Sign-up to receive the latest news and ratings for CLIGF and its competitors with MarketBeat's FREE daily newsletter.


Clinigen Group (OTCMKTS:CLIGF) Frequently Asked Questions

What is Clinigen Group's stock symbol?

Clinigen Group trades on the OTCMKTS under the ticker symbol "CLIGF."

Has Clinigen Group been receiving favorable news coverage?

News articles about CLIGF stock have been trending somewhat negative recently, InfoTrie reports. The research firm scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Clinigen Group earned a daily sentiment score of -1.2 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Clinigen Group.

Who are some of Clinigen Group's key competitors?

What other stocks do shareholders of Clinigen Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Clinigen Group investors own include CareDx (CDNA), eHealth (EHTH), Aeglea Bio Therapeutics (AGLE), Aqua Metals (AQMS), Iovance Biotherapeutics (IOVA), TapImmune (MRKR), Novavax (NVAX), Opko Health (OPK), Sol Gel Technologies (SLGL) and Tandem Diabetes Care (TNDM).

How do I buy shares of Clinigen Group?

Shares of CLIGF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Clinigen Group's stock price today?

One share of CLIGF stock can currently be purchased for approximately $11.37.

How big of a company is Clinigen Group?

Clinigen Group has a market capitalization of $1.39 billion and generates $591.34 million in revenue each year. The company earns $6.78 million in net income (profit) each year or $0.69 on an earnings per share basis. Clinigen Group employs 1,133 workers across the globe.View Additional Information About Clinigen Group.

What is Clinigen Group's official website?

The official website for Clinigen Group is http://www.clinigengroup.com/.

How can I contact Clinigen Group?

Clinigen Group's mailing address is PITCAIRN HOUSE CROWN SQUARE FIRST AVENUE, Burton-on-Trent X0, DE14 2WW. The company can be reached via phone at 44-12-8349-5010.


MarketBeat Community Rating for Clinigen Group (OTCMKTS CLIGF)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  80 (Vote Outperform)
Underperform Votes:  113 (Vote Underperform)
Total Votes:  193
MarketBeat's community ratings are surveys of what our community members think about Clinigen Group and other stocks. Vote "Outperform" if you believe CLIGF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLIGF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel